Delivery Order SPE2DB22D1017-SPE2DB25FG6SJ
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $67,827.51 firm fixed-price delivery order is for the supply of 4,568,274,985 units of the pharmaceutical drug NITAZOXANIDE 500 MG TABLET 6S. The contract has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,041.50, is for the delivery of 4566545462 - NITAZOXANIDE 500 MG TABLET 6S and has a completion date of November 26, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,232.08, is for the delivery of 4566627218 NITAZOXANIDE 500 MG TABLET 6S. The contract has a firm fixed price and an ultimate completion date of December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $30,921.83 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor. The contract is for the supply of 4,565,440 units of the pharmaceutical product Nitazoxanide 500 mg tablets. The ultimate completion date is August 14, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $37,071.03, is for the delivery of 4,567,908,563 units of the drug Nitazoxanide 500 mg tablets. The contract has a completion date of April 15, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Nitazoxanide 500 mg tablets, to the Defense Logistics Agency (DLA). The $2,515.38 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 8, 2023, with a completion date of August 9, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
- This federal contract award, valued at $2,727.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a delivery order for 4,564,325,417 units of the drug Nitazoxanide 500 mg tablets, with a completion date of April 19, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,563.48 firm-fixed-price contract is for the supply of 4,567,278,099 tablets of the drug Nitazoxanide 500 mg. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award, valued at $39,110.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567118252 nitazoxanide 500 mg tablets, a pharmaceutical product, with a period of performance through February 3, 2025. This is a firm-fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitazoxanide 500 mg tablets, a medication used to treat certain infections. The contract has a ceiling value of $2,934.67 and a performance period ending on June 9, 2025. It is a Firm Fixed Price contract, indicating predetermined pricing. This award is not...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG6SJDelivery Order
This is a $11,591.21 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4568723410 - NITAZOXANIDE 500 MG TABLET 6S, with a completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov since 2002, and serves as a critical supplier of medical and pharmaceutical products to federal agencies, with a focus on delivering a comprehensive range of medications, medical devices, and healthcare commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 7/7/25 |